Central America vs France: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
France
96.0%
in 2024
Central America rank
13th
France rank
16th
Proportion of the target population who received a 3rd dose of over time
- Central America
- France
How they compare
France currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes France's figure about 1.2 times Central America's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was France ahead.
Central America ranks 13th and France ranks 16th of 37 groups.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central America | France | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.5% | 90.5% | 4.0% | France |
| 2020s | 81.4% | 95.6% | 14.2% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or France?
- France, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and France?
- 16.0%, with France ahead.
- How many years of comparable data are there for Central America and France?
- 15 years are reported by both, from 2010 to 2024.
- How do Central America and France rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and France ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.